HIV and fatty liver: a hidden danger revealed?

NCT ID NCT05023044

Ongoing Knowledge-focused Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 19 times

Summary

This study follows 400 adults with HIV to learn how nonalcoholic fatty liver disease (NAFLD) progresses in this group. Researchers will use a non-invasive scan to measure liver fat and stiffness over one year. No new treatments are tested; the goal is to fill knowledge gaps and guide future care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Duke University

Durham, North Carolina, 27710, United States
Indiana University

Indianapolis, Indiana, 46202, United States
Johns Hopkins University

Baltimore, Maryland, 21287, United States
University of Alabama

Birmingham, Alabama, 35233, United States
University of California, San Diego

San Diego, California, 92121, United States
University of California, San Francisco

San Francisco, California, 94143, United States
University of Texas

Houston, Texas, 77030, United States
Virginia Commonwealth University

Richmond, Virginia, 23284, United States

Conditions

Explore the condition pages connected to this study.

HIV NAFLD NASH - NONALCOHOLIC STEATOHEPATITIS